Project develops cloud-based digital testing for cardiac devices and drugs, suggesting new solutions in treating cardiovascular diseases.
A cloud-based platform for seamless digital testing of cardiac medical devices and drugs Cardiovascular diseases affect 15 million people in Europe, and digital solutions are now seen as very useful tools in the search for new drugs and medical devices. SimCardioTest is a four-year project funded by the European Commission that aims to develop credible computer modelling and simulation approaches on a cloud-based platform for testing cardiac drugs and devices in silico.
No takes yet. Share an insight, caveat, or question.
Barbier et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: